This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Novartis Ag, Unversität Zürich. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bartenheim, DE (2012)
- Bartenheim, FR (2010 - 2016)
Company Filing History:
4 out of 3,975 
2 out of 276 
Years Active: 2010-2016
Title: The Innovative Contributions of Anis Khusro Mir
Introduction
Anis Khusro Mir, an accomplished inventor based in Bartenheim, France, has made significant strides in the field of pharmaceutical inventions. With a total of four patents to his name, he has dedicated his career to pioneering solutions for complex medical conditions, showcasing a commitment to innovation in healthcare.
Latest Patents
Among his latest patents, Mir has developed groundbreaking treatments, including:
1. The use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid for treating symptoms associated with Rett syndrome.
2. The application of an S1P receptor modulator in the treatment or prevention of diseases dependent on brain-derived neurotrophic factor (BDNF) expression.
3. An antibody (11C7) that targets Nogo-A and its pharmaceutical applications, involving molecules such as monoclonal antibodies or Fab fragments capable of binding to the human NogoA polypeptide, aiding in nerve repair.
These patents embody a blend of innovative chemistry and biology, aimed at revolutionizing treatment options for patients.
Career Highlights
Anis Khusro Mir has worked with prominent organizations throughout his career, including Novartis AG and the University of Zurich. His experience in these esteemed institutions allows him to leverage advanced research and development practices, enhancing the scope of his innovative endeavors.
Collaborations
Mir has collaborated with notable coworkers in his field, such as Carmen Barske and Martin E. Schwab. These partnerships have played a vital role in advancing his research and enhancing the potential impact of his inventions on the scientific community.
Conclusion
Anis Khusro Mir exemplifies the spirit of innovation within the pharmaceutical industry. Through his patents and collaborations, he has contributed significantly to medical science, particularly in the realm of neurological treatments. His work continues to inspire future inventors and healthcare professionals working towards transformative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile